D. Montgomery

940 total citations
33 papers, 731 citations indexed

About

D. Montgomery is a scholar working on Pharmacology, Psychiatry and Mental health and Biological Psychiatry. According to data from OpenAlex, D. Montgomery has authored 33 papers receiving a total of 731 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pharmacology, 15 papers in Psychiatry and Mental health and 9 papers in Biological Psychiatry. Recurrent topics in D. Montgomery's work include Treatment of Major Depression (18 papers), Tryptophan and brain disorders (9 papers) and Bipolar Disorder and Treatment (8 papers). D. Montgomery is often cited by papers focused on Treatment of Major Depression (18 papers), Tryptophan and brain disorders (9 papers) and Bipolar Disorder and Treatment (8 papers). D. Montgomery collaborates with scholars based in United Kingdom, United States and South Africa. D. Montgomery's co-authors include Stuart Montgomery, R McAuley, S.A. Montgomery, David S. Baldwin, Marie Åsberg, Naomi Fineberg, R A Braithwaite, Sheila Dawling, Scott Montgomery and Lil Träskman and has published in prestigious journals such as Clinical Pharmacokinetics, Acta Psychiatrica Scandinavica and British Journal of Clinical Pharmacology.

In The Last Decade

D. Montgomery

32 papers receiving 654 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Montgomery United Kingdom 16 383 366 204 156 136 33 731
D.P. Doogan United Kingdom 11 478 1.2× 399 1.1× 82 0.4× 177 1.1× 103 0.8× 14 765
Norma L. Pearson United States 3 443 1.2× 282 0.8× 117 0.6× 199 1.3× 166 1.2× 5 776
Mary E. Sayler United States 13 561 1.5× 385 1.1× 239 1.2× 300 1.9× 59 0.4× 26 834
J C Bosomworth United States 9 457 1.2× 324 0.9× 184 0.9× 166 1.1× 39 0.3× 10 713
Robert E. McCue United States 17 475 1.2× 449 1.2× 101 0.5× 154 1.0× 127 0.9× 32 840
N Reisby Denmark 14 520 1.4× 483 1.3× 153 0.8× 296 1.9× 102 0.8× 27 1.1k
Alan D. Feiger United States 12 447 1.2× 350 1.0× 78 0.4× 233 1.5× 89 0.7× 16 708
Charles S. Wilcox United States 16 320 0.8× 275 0.8× 171 0.8× 272 1.7× 73 0.5× 27 806
B. Woggon Switzerland 11 172 0.4× 274 0.7× 105 0.5× 123 0.8× 60 0.4× 62 599
Wolfram Bender Germany 16 418 1.1× 408 1.1× 220 1.1× 256 1.6× 184 1.4× 30 952

Countries citing papers authored by D. Montgomery

Since Specialization
Citations

This map shows the geographic impact of D. Montgomery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Montgomery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Montgomery more than expected).

Fields of papers citing papers by D. Montgomery

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Montgomery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Montgomery. The network helps show where D. Montgomery may publish in the future.

Co-authorship network of co-authors of D. Montgomery

This figure shows the co-authorship network connecting the top 25 collaborators of D. Montgomery. A scholar is included among the top collaborators of D. Montgomery based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Montgomery. D. Montgomery is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Anderson, Annaliesa S., et al.. (2024). Bilateral trismus in the setting of a unilateral stroke of the internal capsule. The American Journal of the Medical Sciences. 367. S73–S73.
2.
Montgomery, D., et al.. (2001). ECNP Consensus Meeting March 2000 Nice. European Neuropsychopharmacology. 11(1). 79–88. 36 indexed citations
3.
Montgomery, D., et al.. (1994). Lack of efficacy of fluoxetine in recurrent brief depression and suicidal attempts. European Archives of Psychiatry and Clinical Neuroscience. 244(4). 211–215. 36 indexed citations
4.
Montgomery, D., R.C. Evans, & Stuart Montgomery. (1993). Pharmacological differences between brief and major depressions. European Neuropsychopharmacology. 3(3). 214–215. 5 indexed citations
5.
Fineberg, Naomi, D. Montgomery, R.C. Evans, & Stuart Montgomery. (1993). Is long-term treatment effective in OCD?. European Neuropsychopharmacology. 3(3). 289–291. 2 indexed citations
6.
Montgomery, Stuart, et al.. (1992). The Provocation and Prevention of Suicide Attempts. International Clinical Psychopharmacology. 6. 28–34. 3 indexed citations
7.
Fineberg, Naomi, et al.. (1992). Serotonin reuptake inhibitors are the treatment of choice in obsessive compulsive disorder. International Clinical Psychopharmacology. 7. 43–43. 28 indexed citations
8.
Montgomery, Stuart, et al.. (1990). Plasma-Level Response Relationships with Fluoxetine and Zimelidine. Clinical Neuropharmacology. 13. S71–S75. 27 indexed citations
9.
Montgomery, D., et al.. (1990). [Biological treatments in obsessive-compulsive disorder].. PubMed. 16 Spec No. 335–9. 3 indexed citations
10.
Montgomery, Stuart, et al.. (1989). Prophylactic Treatment of Depression: A Public Health Issue. Neuropsychobiology. 22(4). 214–219. 10 indexed citations
11.
Montgomery, Stuart, et al.. (1987). Pharmacological Specificity Is Not the Same as Clinical Selectivity. PubMed. 3. 179–183. 10 indexed citations
12.
Montgomery, S.A., et al.. (1983). Plasma levels and clinical response with imipramine in a study comparing efficacy with mianserin and nomifensine.. British Journal of Clinical Pharmacology. 15(S2). 205S–211S. 15 indexed citations
13.
Montgomery, Stuart, et al.. (1981). A double blind comparison of zimelidine and amitriptyline in endogenous depression. Acta Psychiatrica Scandinavica. 63(s290). 314–327. 83 indexed citations
14.
Montgomery, S.A., R McAuley, D. Montgomery, Sheila Dawling, & R A Braithwaite. (1980). Plasma concentration of clomipramine and desmethylclomipramine and clinical response in depressed patients.. PubMed. 56 Suppl 1. 130–3. 14 indexed citations
15.
Montgomery, Stuart, et al.. (1979). Amitriptyline plasma concentration and clinical response.. BMJ. 1(6158). 230.2–231. 46 indexed citations
16.
Montgomery, Stuart, R McAuley, D. Montgomery, R A Braithwaite, & Sheila Dawling. (1979). Original Article. Clinical Pharmacokinetics. 4(2). 129–136. 29 indexed citations
17.
Montgomery, S.A., et al.. (1979). Mianserin plasma levels and differential clinical response in endogenous and reactive depression.. PubMed. 78(5). 798–812. 14 indexed citations
18.
Montgomery, Stuart, Börje Cronholm, Marie Åsberg, & D. Montgomery. (1978). Differential effects on suicidal ideation of mianserin, maprotiline and amitriptyline.. British Journal of Clinical Pharmacology. 5(S1). 77S–80S. 21 indexed citations
19.
Montgomery, Stuart, R McAuley, & D. Montgomery. (1978). Relationship between mianserin plasma levels and antidepressant effect in a double‐blind trial comparing a single night‐time and divided daily dose regimens.. British Journal of Clinical Pharmacology. 5(S1). 71S–76S. 37 indexed citations
20.
Montgomery, D. & M. A. Ogryzlo. (1960). Comparison of the uricosuric effect of sulfinpyrazone (anturan) and zoxazolamine (flexin).. PubMed. 83. 885–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026